ArticleCureus2025
Risk Factors for the Failure of Non-surgical Treatment in Pneumothorax.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFew studies have thoroughly investigated the factors influencing the clinical course of pneumothorax at each stage of treatment. This study aimed to address this gap by examining these factors.
methodsWe conducted a single-center retrospective study involving patients with pneumothorax aged 20 years or older admitted to our hospital. Patients were divided into two groups: those successfully treated with chest tube drainage alone (Group A) and those who required additional treatment (Group B). Excluding patients requiring surgical treatment, patients in Group B were subsequently divided into two groups: those successfully treated with non-surgical secondary treatments (Group C) and those who were not (Group D). Clinical factors were compared between Groups A and B and between Groups C and D.
resultsThree hundred and ninety-five patients were included in this analysis. A comparison between Group A (148 patients) and B (247 patients) revealed significant differences in the presence of interstitial lung disease (ILD) (6.1% vs. 13.8%,
conclusionPatients with a history of ILD are more likely to require additional treatment after chest tube drainage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.